Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-05

FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for LITHIUM CARBONATE ER from Glenmark Pharmaceuticals Inc., USA, related to the generic lithium carbonate extended-rele…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate ER (Lithium carbonate)

Snippet

SUPPL AP for LITHIUM CARBONATE ER (LITHIUM CARBONATE)